InnovAge (INNV)
(Delayed Data from NSDQ)
$3.91 USD
+0.11 (2.89%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.85 -0.06 (-1.53%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INNV 3.91 +0.11(2.89%)
Will INNV be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for INNV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INNV
InnovAge Holding Corp. (INNV) Reports Q2 Loss, Tops Revenue Estimates
InnovAge Holding Corp. (INNV) Reports Q1 Loss, Tops Revenue Estimates
INNV: What are Zacks experts saying now?
Zacks Private Portfolio Services
InnovAge Holding Corp. (INNV) Reports Q4 Loss, Tops Revenue Estimates
InnovAge Holding Corp. (INNV) Soars 15.4%: Is Further Upside Left in the Stock?
HealthEquity (HQY) Beats Q2 Earnings and Revenue Estimates
Other News for INNV
InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently with High-Quality Care
InnovAge to Announce Fiscal Third Quarter 2024 Financial Results and Host Conference Call Tuesday, May 7, 2024
3 Healthcare Stocks Short Sellers Are Prescribing for Trouble
InnovAge Launches First PACE Center in Florida Providing Comprehensive Healthcare Program for Seniors to Promote Independence
InnovAge Holding: A Cautious Hold Amidst Growth Opportunity and Execution Hurdles